Michelle J. Khan
Research Subjects
Michelle J. Khan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Karen K. Smith-McCune
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of California San Francisco, San Francisco, CA
2 shared publicationsAmaranta D. Craig
University of California San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences
1 shared publicationBlanca R. Cendejas
University of California, San Francisco, School of Medicine, San Francisco, California
1 shared publicationDavid Chelmow
Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, USA
1 shared publicationDeborah Kamali
University of California San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences
1 shared publicationE.J. Mayeaux
Department of Family and Preventive Medicine, Department of Obstetrics and Gynecology, University of South Carolina School of Medicine, Columbia, SC, USA
1 shared publication
Latest Publications
- 1 October 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (1) , 209
Focal treatment for high-grade cervical intraepithelial neoplasia: a pilot study
- 1 October 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (1) , 209
Focal treatment for high-grade cervical intraepithelial neoplasia: a pilot study
- 1 May 2016
- Published by Elsevier in Gynecologic Oncology
- Vol. 141 (2) , 364-370
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results
- 1 May 2016
- Published by Elsevier in Gynecologic Oncology
- Vol. 141 (2) , 364-370
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results
- 1 March 2015
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 212 (3) , 291-297
Does treatment for cervical and vulvar dysplasia impact women’s sexual health?
- 1 March 2015
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 212 (3) , 291-297
Does treatment for cervical and vulvar dysplasia impact women’s sexual health?
- 1 June 2014
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 123 (6) , 1339-1343
Treatment of Cervical Precancers
Both ablative (cervical cryotherapy, laser ablation) and excisional methods (loop electrosurgical excision procedure, cold knife conization) can be effective at treating cervical precancer. Excisional procedures are associated with adverse obstetric outcomes including preterm delivery and perinatal mortality with the depth of excision potentially contributing to the adverse outcomes. Ablative therapies are now used much less commonly than loop electrosurgical excision procedure but have less of an effect on adverse obstetric outcomes and hence are effective alternatives for treating cervical precancer in reproductive-aged women. Morphometric data indicate that the vast majority of precancerous lesions are less than 5 mm deep, suggesting that treatments that reach 6–7 mm below the epithelium are adequate in women with satisfactory colposcopy. Cone biopsies, “top-hat” loop electrosurgical excision procedures, or the use of loop electrodes greater than 10 mm are therefore unnecessary for the majority of reproductive-aged women and increase risk of adverse obstetric outcomes. New consensus guidelines allow observation instead of treatment in appropriately selected young women. Until the association of excisional methods with adverse obstetric outcomes is clarified with more data, ablative methods should be revitalized and used by health care providers in appropriately selected patients. Treatment should be individualized based on patient’s age, fertility desires, and colpopathologic findings.
- 1 June 2014
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 123 (6) , 1339-1343
Treatment of Cervical Precancers
Both ablative (cervical cryotherapy, laser ablation) and excisional methods (loop electrosurgical excision procedure, cold knife conization) can be effective at treating cervical precancer. Excisional procedures are associated with adverse obstetric outcomes including preterm delivery and perinatal mortality with the depth of excision potentially contributing to the adverse outcomes. Ablative therapies are now used much less commonly than loop electrosurgical excision procedure but have less of an effect on adverse obstetric outcomes and hence are effective alternatives for treating cervical precancer in reproductive-aged women. Morphometric data indicate that the vast majority of precancerous lesions are less than 5 mm deep, suggesting that treatments that reach 6–7 mm below the epithelium are adequate in women with satisfactory colposcopy. Cone biopsies, “top-hat” loop electrosurgical excision procedures, or the use of loop electrodes greater than 10 mm are therefore unnecessary for the majority of reproductive-aged women and increase risk of adverse obstetric outcomes. New consensus guidelines allow observation instead of treatment in appropriately selected young women. Until the association of excisional methods with adverse obstetric outcomes is clarified with more data, ablative methods should be revitalized and used by health care providers in appropriately selected patients. Treatment should be individualized based on patient’s age, fertility desires, and colpopathologic findings.
- 30 June 2013
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 40 (2) , 317-337
Nongenital Human Papillomavirus Disease
- 30 June 2013
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 40 (2) , 317-337
Nongenital Human Papillomavirus Disease